Lava Therapeutics B.V. Stock Forecast, Price & News

+0.99 (+6.60 %)
(As of 04/13/2021 12:00 AM ET)
Today's Range
Now: $16.00
50-Day Range N/A
52-Week Range
Now: $16.00
Volume16,751 shs
Average Volume181,679 shs
Market Capitalization$405.63 million
P/E RatioN/A
Dividend YieldN/A
There is no company description available for LAVA Therapeutics BV.

Industry, Sector and Symbol

Industry --
Current SymbolNASDAQ:LVTX
Year FoundedN/A



Sales & Book Value

Annual SalesN/A



Market Cap$405.63 million
Next Earnings DateN/A
OptionableNot Optionable


Overall MarketRank

0.00 out of 5 stars

-- Sector

250th out of 266 stocks

-- Industry

252nd out of 268 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
+0.99 (+6.60 %)
(As of 04/13/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive LVTX News and Ratings via Email

Sign-up to receive the latest news and ratings for LVTX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Lava Therapeutics B.V. (NASDAQ:LVTX) Frequently Asked Questions

What stocks does MarketBeat like better than Lava Therapeutics B.V.?

Wall Street analysts have given Lava Therapeutics B.V. a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Lava Therapeutics B.V. wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Lava Therapeutics B.V.'s key competitors?

When did Lava Therapeutics B.V. IPO?

(LVTX) raised $100 million in an IPO on Thursday, March 25th 2021. The company issued 6,700,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan, Jefferies and SVB Leerink acted as the underwriters for the IPO and Kempen & Co. was co-manager.

What is Lava Therapeutics B.V.'s stock symbol?

Lava Therapeutics B.V. trades on the NASDAQ under the ticker symbol "LVTX."

When does Lava Therapeutics B.V.'s quiet period expire?

Lava Therapeutics B.V.'s quiet period expires on Tuesday, May 4th. Lava Therapeutics B.V. had issued 6,700,000 shares in its IPO on March 25th. The total size of the offering was $100,500,000 based on an initial share price of $15.00. During Lava Therapeutics B.V.'s quiet period, underwriters and any insiders involved in the IPO are restricted from issuing any earnings forecasts or research reports for the company because of SEC regulations. Following the end of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

How do I buy shares of Lava Therapeutics B.V.?

Shares of LVTX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Lava Therapeutics B.V.'s stock price today?

One share of LVTX stock can currently be purchased for approximately $16.00.

How much money does Lava Therapeutics B.V. make?

Lava Therapeutics B.V. has a market capitalization of $405.63 million.

This page was last updated on 4/13/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.